colon cancer
| 7 min read
They’re approved by the FDA and Medicare and inching closer to widespread adoption nationally. But how good are they at detecting colorectal cancer?
| 6 min read
Judy Sebolt-Leopold and her team at MEKanistic Therapeutics developed a single molecule targeting two kinase enzymes that drive resistance to cancer therapies.
| 6 min read
Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.
Page 1 of 1 - 3 Total Items
